Skip to main content

Advertisement

Log in

CK1δ kinase activity is modulated by protein kinase C α (PKCα)-mediated site-specific phosphorylation

  • Original Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Abstract

Cellular signal transduction components are usually regulated not only on transcriptional or translational level, but also by posttranslational modifications. Among these, reversible phosphorylation represents the most abundant modification. In general, phosphorylation events are essential for regulating the activity of central signal transduction proteins, also including kinases itself. Members of the CK1 family can be found as central signal transduction proteins in numerous cellular pathways. Due to its wide variety of cellular functions the activity of CK1 family members has to be tightly regulated. We previously reported that PKA and Chk1 are able to phosphorylate CK1δ within its C-terminal regulatory domain, consequently resulting in altered CK1 kinase activity. In the present study, we show by several methods that protein kinase C α (PKCα) as well is able to phosphorylate CK1δ at its C-terminally located residues S328, T329, and S370. Furthermore, we analyze the functional consequences of PKCα-mediated phosphorylation on CK1δ kinase activity. Mutation of S328, T329, or S370 to alanine dramatically alters the kinetic parameters of CK1δ. By using the PKCα-specific inhibitor Go-6983 in a selected cell culture model, we finally show that the in vitro detected regulatory connection between PKCα and CK1δ is also relevant in the cellular context. Taken together, these data contribute to a deeper understanding of cellular signal transduction networks thereby helping to form a basis for the development of future therapeutic concepts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29(11):1039–1045. doi:10.1038/nbt.2017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bischof J, Randoll SJ, Sussner N, Henne-Bruns D, Pinna LA, Knippschild U (2013) CK1delta kinase activity is modulated by Chk1-mediated phosphorylation. PLoS One 8(7):e68803. doi:10.1371/journal.pone.0068803

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cruciat CM (2014) Casein kinase 1 and Wnt/beta-catenin signaling. Curr Opin Cell Biol 31:46–55. doi:10.1016/j.ceb.2014.08.003

    Article  CAS  PubMed  Google Scholar 

  • Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Korner R, Greff Z, Keri G, Stemmann O, Mann M (2008) Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell 31(3):438–448. doi:10.1016/j.molcel.2008.07.007

    Article  CAS  PubMed  Google Scholar 

  • Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 105(31):10762–10767. doi:10.1073/pnas.0805139105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dulla K, Daub H, Hornberger R, Nigg EA, Korner R (2010) Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression. Mol Cell Proteomics 9(6):1167–1181. doi:10.1074/mcp.M900335-MCP200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dumaz N, Milne DM, Meek DW (1999) Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15. FEBS Lett 463(3):312–316 (S0014-5793(99)01647-6 [pii])

    Article  CAS  PubMed  Google Scholar 

  • Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ (2013) A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. Biochem J 451(2):313–328. doi:10.1042/BJ20121418

    Article  CAS  PubMed  Google Scholar 

  • Giamas G, Hirner H, Shoshiashvili L, Grothey A, Gessert S, Kuhl M, Henne-Bruns D, Vorgias CE, Knippschild U (2007) Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo. Biochem J 406(3):389–398. doi:10.1042/BJ20070091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Graff JR, McNulty AM, Hanna KR, Konicek BW, Lynch RL, Bailey SN, Banks C, Capen A, Goode R, Lewis JE, Sams L, Huss KL, Campbell RM, Iversen PW, Neubauer BL, Brown TJ, Musib L, Geeganage S, Thornton D (2005) The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts. Cancer Res 65(16):7462–7469. doi:10.1158/0008-5472.CAN-05-0071

    Article  CAS  PubMed  Google Scholar 

  • Graves PR, Haas DW, Hagedorn CH, DePaoli-Roach AA, Roach PJ (1993) Molecular cloning, expression, and characterization of a 49-kilodalton casein kinase I isoform from rat testis. J Biol Chem 268(9):6394–6401

    CAS  PubMed  Google Scholar 

  • Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, Johannes FJ (1996) Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392(2):77–80 (0014579396007855 [pii])

    Article  CAS  PubMed  Google Scholar 

  • Knippschild U, Milne D, Campbell L, Meek D (1996) p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage. Oncogene 13(7):1387–1393

    CAS  PubMed  Google Scholar 

  • Knippschild U, Milne DM, Campbell LE, DeMaggio AJ, Christenson E, Hoekstra MF, Meek DW (1997) p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs. Oncogene 15(14):1727–1736. doi:10.1038/sj.onc.1201541

    Article  CAS  PubMed  Google Scholar 

  • Knippschild U, Kruger M, Richter J, Xu P, Garcia-Reyes B, Peifer C, Halekotte J, Bakulev V, Bischof J (2014) The CK1 family: contribution to cellular stress response and its role in carcinogenesis. Front Oncol 4:96. doi:10.3389/fonc.2014.00096

    Article  PubMed  PubMed Central  Google Scholar 

  • Kulikov R, Winter M, Blattner C (2006) Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. J Biol Chem 281(39):28575–28583. doi:10.1074/jbc.M513311200

    Article  CAS  PubMed  Google Scholar 

  • Mashhoon N, DeMaggio AJ, Tereshko V, Bergmeier SC, Egli M, Hoekstra MF, Kuret J (2000) Crystal structure of a conformation-selective casein kinase-1 inhibitor. J Biol Chem 275(26):20052–20060. doi:10.1074/jbc.M001713200

    Article  CAS  PubMed  Google Scholar 

  • Morgan RT, Woods LK, Moore GE, Quinn LA, McGavran L, Gordon SG (1980) Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma. Int J Cancer 25(5):591–598

    Article  CAS  PubMed  Google Scholar 

  • Obenauer JC, Cantley LC, Yaffe MB (2003) Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31(13):3635–3641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Perez DI, Gil C, Martinez A (2010) Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. Med Res Rev. doi:10.1002/med.20207

    PubMed  Google Scholar 

  • Reyland ME (2009) Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci (Landmark Ed) 14:2386–2399 (3385 [pii])

    Article  CAS  Google Scholar 

  • Richter J, Bischof J, Zaja M, Kohlhof H, Othersen O, Vitt D, Alscher V, Pospiech I, Garcia-Reyes B, Berg S, Leban J, Knippschild U (2014) Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation. J Med Chem 57(19):7933–7946. doi:10.1021/jm500600b

    Article  CAS  PubMed  Google Scholar 

  • Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW, Appella E (2000) Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J Biol Chem 275(13):9278–9283

    Article  CAS  PubMed  Google Scholar 

  • Schittek B, Sinnberg T (2014) Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis. Mol Cancer 13(1):231. doi:10.1186/1476-4598-13-231

    Article  PubMed  PubMed Central  Google Scholar 

  • Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F et al (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266(24):15771–15781

    CAS  PubMed  Google Scholar 

  • van der Geer P, Hunter T (1994) Phosphopeptide mapping and phosphoamino acid analysis by electrophoresis and chromatography on thin-layer cellulose plates. Electrophoresis 15(3–4):544–554

    Article  PubMed  Google Scholar 

  • Venerando A, Ruzzene M, Pinna LA (2014) Casein kinase: the triple meaning of a misnomer. Biochem J 460(2):141–156. doi:10.1042/BJ20140178

    Article  CAS  PubMed  Google Scholar 

  • Zhou H, Di Palma S, Preisinger C, Peng M, Polat AN, Heck AJ, Mohammed S (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 12(1):260–271. doi:10.1021/pr300630k

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. Mirita Franz-Wachtel, Silke Wahl, and Johannes Madlung (Proteome Center Tübingen, University of Tübingen, Germany) for the performed mass spectrometric analyses as well as Annette Blatz and Julia Richter for excellent technical support. ZM gratefully acknowledges the China Scholarship Council (CSC) for his research grant at the University of Ulm. This work was supported by Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung, awarded to Uwe Knippschild (108489).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Uwe Knippschild.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Handling Editor: K. L. Bennett.

Z. Meng and J. Bischof equally contributed and P. Xu and U. Knippschild shared senior authorship.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 584 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meng, Z., Bischof, J., Ianes, C. et al. CK1δ kinase activity is modulated by protein kinase C α (PKCα)-mediated site-specific phosphorylation. Amino Acids 48, 1185–1197 (2016). https://doi.org/10.1007/s00726-015-2154-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-015-2154-3

Keywords

Navigation